Robert Michel - BIO Key Director
| BKYI Stock | USD 1.66 0.05 2.92% |
Director
Mr. Robert J. Michel, CPA., is Director of the Company. Robert J. Michel, 60, has over thirty years of accounting and financial management experience and currently serves as a consultant with Feuer Orlando, LLP, New York, NY based CPA firm. From 2009 until March, 2016, Mr. Michel was the Chief Financial Officer of Asta Funding, Inc., a diversified financial services company operating in five reportable segments in the United States, with the Consumer Receivables segment also operating in South America. Mr. Michel was responsible for all financial matters and SEC reporting. From 2004 until 2009, Mr. Michel served as the Controller and the Director of Financial Reporting and Compliance for Asta Funding. Mr. Michel is a certified public accountant, earned a MBA in Taxation from St. Johns University, and a BS, Business Administration, from Villanova University since 2017.
| Age | 60 |
| Tenure | 7 years |
| Phone | 732 359 1100 |
| Web | https://www.bio-key.com |
Robert Michel Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Michel against BIO Key stock is an integral part of due diligence when investing in BIO Key. Robert Michel insider activity provides valuable insight into whether BIO Key is net buyers or sellers over its current business cycle. Note, BIO Key insiders must abide by specific rules, including filing SEC forms every time they buy or sell BIO Key'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Michel over three weeks ago Acquisition by Robert Michel of 750 shares of Daxor at 8.7 subject to Rule 16b-3 | ||
Robert Michel over three months ago Purchase by Robert Michel of 120 shares of Daxor | ||
Robert Michel over three months ago Purchase by Robert Michel of 500 shares of Daxor | ||
Robert Michel over three months ago Acquisition by Robert Michel of 2000 shares of Daxor subject to Rule 16b-3 |
BIO Key Management Efficiency
The company has return on total asset (ROA) of (0.273) % which means that it has lost $0.273 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2593) %, meaning that it created substantial loss on money invested by shareholders. BIO Key's management efficiency ratios could be used to measure how well BIO Key manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Matthew Nord | ADT Inc | 41 | |
| Bruce Campbell | Senstar Technologies | 64 | |
| Thurgood Marshall | CoreCivic | 64 | |
| Devin Murphy | CoreCivic | 61 | |
| Lee Solomon | ADT Inc | 48 | |
| Eric Press | ADT Inc | 54 | |
| Timothy Donahue | ADT Inc | 66 | |
| Themba Gamedze | Senstar Technologies | 56 | |
| Robert Dennis | CoreCivic | 67 | |
| Charles Jacobi | CoreCivic | 73 | |
| C Jacobi | CoreCivic | 73 | |
| Joseph Russell | CoreCivic | 73 | |
| Christopher Hylen | ADT Inc | 53 | |
| Jacobus Moller | Senstar Technologies | 55 | |
| Machiel Reyneke | Senstar Technologies | 57 | |
| Joseph Murphy | ADT Inc | N/A | |
| Yaganthrie Ramiah | Senstar Technologies | 47 | |
| Tantaswa Nyoka | Senstar Technologies | 43 | |
| Bptkm Gamedze | Senstar Technologies | 55 | |
| Marion Marole | Senstar Technologies | 54 | |
| John Swaite | ADT Inc | N/A | |
Management Performance
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.27 |
BIO Key International Leadership Team
Elected by the shareholders, the BIO Key's board of directors comprises two types of representatives: BIO Key inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BIO. The board's role is to monitor BIO Key's management team and ensure that shareholders' interests are well served. BIO Key's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BIO Key's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Mahnken, VP of Marketing | ||
| Mark Cochran, President PortalGuard | ||
| Cecilia Welch, Chief Officer | ||
| Pieter Knook, Director | ||
| Akintunde Jeje, Managing Africa | ||
| Alex Rocha, Managing EMEA | ||
| Thomas Gilley, Director | ||
| Kwok Wong, MD ViceChairman | ||
| Michael DePasquale, Chairman, CEO and Pres | ||
| Frederick Corsentino, Chief Revenue Officer | ||
| Jianhui Yau, Director | ||
| James Sullivan, Senior Officer | ||
| Thomas Bush, Director | ||
| Fabian Shin, Director | ||
| Robert Michel, Director | ||
| Mira LaCous, Chief Officer | ||
| Charles Romeo, Independent Director | ||
| John Schoenherr, Independent Director | ||
| Barbara Rivera, Director | ||
| Renat Zhdanov, Chief Scientist and VP |
BIO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BIO Key a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (1.06) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 3.73 M | ||||
| Shares Outstanding | 1.81 M | ||||
| Shares Owned By Insiders | 4.90 % | ||||
| Shares Owned By Institutions | 5.40 % | ||||
| Number Of Shares Shorted | 18.84 K | ||||
| Price To Earning | (2.55) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BIO Key in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BIO Key's short interest history, or implied volatility extrapolated from BIO Key options trading.
Pair Trading with BIO Key
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIO Key position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIO Key will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to BIO Key could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BIO Key when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BIO Key - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BIO Key International to buy it.
The correlation of BIO Key is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BIO Key moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BIO Key International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BIO Key can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is BIO Key's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.